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Abstract
This commentary intends to instigate discussions about epidemiologic estimates and their interpretation of
attributable fractions (AFs) and the burden of disease (BOD) of cancers due to factors at workplaces. By examining
recent work that aims to estimate the number of cancers attributable to shift-work in Britain, we suggest that (i)
causal, (ii) practical and (iii) methodological areas of concern may deter us from attributable caseload estimations
of cancers at this point in time. Regarding (i), such calculations may have to be avoided as long as we lack
established causality between shift-work and the development of internal cancers. Regarding (ii), such calculations
may have to be avoided as long as we can neither abandon shift-work nor identify personnel that may be
unaffected by shift-work factors. Regarding (iii), there are at least four methodological pitfalls which are likely to
make AF calculations uninterpretable at this stage. The four pitfalls are: (1) The use of Levin’s 1953 formula in case
of adjusted relative risks; (2) The use of broad definitions of exposure in calculations of AFs; (3) The non-additivity
of AFs across different levels of exposure and covariables; (4) The fact that excess mortality counts are misleading
due to the fact that a human being dies exactly once - a death may occur earlier or later, but a death cannot
occur more than once nor can it be avoided altogether for any given individual. Overall, causal, practical and
methodological areas of concern should be diligently considered when performing and interpreting AF or BOD
computations which - at least at the present time - may not be defensible.
Introduction
Estimates of the burden of disease (BOD) at a popula-
tion level have been further developed during the last
two decades. This has mainly been done with the aim to
inform the community and policy makers about the size
of a given problem [1]. A world-wide application and an
overview of the projects performed were presented in a
series of papers. These publications described the World
Health Organisation (WHO) programme on the global
BOD and comparative risk assessment while focussing
on the impact of occupational causes [2-4]. Methodolo-
gical details were published separately [5]. Recent results
regarding the WHO global BOD programme are avail-
able on-line [6]. The backbone of all calculations is an
estimate of the population attributable fraction (AF) of
diseases or deaths (see definition below). Steenland and
Armstrong gave a methodological overview on how to
calculate AFs and related statistics [7] which has already
been commented on [8]. Recently, the BOD methodol-
ogy was refined and extended by Dr. Rushton and col-
leagues in order to estimate the cancer burden due to
occupational causes in the UK, and to prioritise control
measures in an evidence-based manner [9-11]. More-
over, the methodology was used to calculate the cancer
burden related to occupational exposures in Europe,
extended by a socio-economic assessment and with the
aim to amend the EU carcinogen directive [12]. This
recent work not only focused on International Agency
for Research on Cancer (IARC) Group 1 substances
("established human carcinogens” according IARC cate-
gorisation) but it also included IARC Group 2a sub-
stances ("probable carcinogens”), and even some Group
2b substances ("possible carcinogens”), such as hydra-
zine and refractory ceramic fibres.
In brief, Rushton et al. followed and refined the AF
procedures as outlined and applied previously [5-7].
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basis to estimate a relative risk (RR) for the cancer end-
point of interest. Second, they calculated the prevalence
of exposure in a chosen target population by transfer-
ring estimates from available (external) sources. Third,
they estimated the number and fraction of exposed
workers in the target population time-dependently,
while taking latency considerations and employment
turnover estimates into account. Finally, they calculated
AFs and absolute BOD counts by applying formulas that
link the RRs taken from the key studies and the derived
fractions and numbers of exposed workers (or of
exposed cases) in the target population (see below for
an explanation of the formulas).
This paper is a commentary on the recent work which
aims to estimate the number of cancers attributable to
workplace exposures. By examining this strategy of esti-
mating cancer attributable to shift-work in Britain, [10]
we have identified a couple of problems that may be
involved. Most of our commentary is applicable to other
BOD projects as well [1-4,6,12].
The example of attributing burden of cancer to
shift-work
In the course of an expert meeting convened by IARC,
scientists came to the conclusion that “shift-work that
involves circadian disruption is probably carcinogenic to
humans” (Group 2A) [13]. This classification prompted
considerable scientific and public interest and numerous
- both experimental and epidemiological - studies are
underway to settle whether there is a chain of cancer
causation or not. Let us suppose that IARC experts
were to arrive at a Group 1 classification, i.e., they were
to conclude from the available evidence in coming years
that there are definite links between shift-work and the
development of internal cancers [14]. In such case, we
would certainly want to know the impact of such cancer
causation in occupational settings. As outlined in the
Introduction, tools to arrive to the said quantitative
answers by estimating BOD have been developed in the
literature. Moreover, the theory and the methodology of
such studies have considerably improved in the last
decade.
When Rushton et al. “estimated the current burden of
cancer in Britain attributable to past occupational expo-
sures for International Agency for Research on Cancer
(IARC) group 1 (established) and 2A (probable) carcino-
gens” in 2010 [10], they included analyses regarding
cancer registrations in women which were “attributable”
to shift-work. While Dr. Straif, a contributor to the
aforementioned IARC classification of shift-work, com-
mended prior work [9] which estimated “attributable
fractions and numbers for incidence and mortality” [15],
the 2010 calculations came as a surprise to others for
several reasons. In 2007, there had already been public
discussions, as referred to below, which suggested that
such calculations may be uninterpretable.
Clearly, Dr. Rushton and colleagues are to be credited
for having taken the lead to combine and analyse large
databases in order to attribute incident cancers and can-
cer deaths to occupational factors. Equally clearly, we
think that such work may have to be considered with
caution due to concerns in three areas:
(i) Causal area of concern: Is it appropriate to make
such calculations when we lack established causality?
(ii) Practical area of concern: Is it appropriate to make
such calculations when we lack an effective alternative
to shift-work or effective means to intervene to the end
of prevention?
(iii) Methodological area of concern: Is it appropriate
to make such calculations when their interpretation may
be complicated by open methodological questions?
Shift-work, including night work, is widespread and
the allegedly linked and attributed cancers of the breast
are epidemic. Therefore, attributable fraction and attri-
butable caseload estimations may receive considerable
attention and deserve diligent scrutiny.
Evaluation of concerns
During the Cologne Symposium in 2002 titled “Light,
Endocrine Systems and Cancer - Facts and Research
Perspectives” [16], possible links between shift-work and
breast cancer were one focus of discussion. It should be
noted that attributable caseload estimates were already
presented [17] and challenged [18] at the symposium.
Poole [18] illustrated key pitfalls of such computations
in one of four invited critical summaries of the Cologne
Symposium:
Regarding (i): “.... such computations are usually
reserved for situations in which a high degree of certainty
in the causal hypothesis has accrued. The reason for this
caution is that attributable caseload figures are highly
newsworthy and exceedingly liable to sensationalisation”
[18].
With regard to (i), this condition is certainly not ful-
filled to-date. When the invited IARC experts concluded
in October of 2007 that “shift-work that involves circa-
dian disruption is probably carcinogenic to humans”
(Group 2A) [13], it came as a surprise to many
researchers. Some readers may argue that “probably car-
cinogenic” already suggests the much-needed high
degree of certainty in the causal hypothesis. However,
we think that the word “probably” implies a certain
degree of uncertainty. Granted, on balance of all avail-
able evidence, the IARC experts concluded that there
was more evidence for than against the alleged causal
links. However, the judgment or anticipation that there
is “probably” a causal link is coupled with the
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evidence did not suffice to infer causality with the
necessary high degree of certainty in October of 2007
[19]. The current IARC Group 2A classification can not
be viewed as a one-way street to a Group 1 classification
[20] which, in our opinion, could be considered as a
necessary requirement for calculations of attributable
caseload estimates. By including both proven and prob-
able human carcinogens in their AF analyses, IARC’s
diligent efforts to judge what causes and what may
cause cancer could become blurred. Against this back-
ground, statements such as “54% of cancer registrations
in women are attributable to shift work (breast cancer)”
might be considered somewhat premature [10]. Remark-
ably, according to Table 2 in [10], breast cancer registra-
tions in 2004 attributable to “shift work (including flight
personnel)” are estimated to be second in rank,
exceeded only by asbestos exposure, among all occupa-
tionally “caused” cancers.
Regarding (ii): “Without a proposed intervention ....
attributable fraction and attributable caseload estimates
are meaningless”.. . . .“the interest and intent is in elimi-
nating an exposure entirely ....” [18].
With regard to (ii), attributable caseload computations
in [10] are - technically - for a highly implausible, “uto-
pian” society with no shift-work. Alternatives are equally
indefensible today and, presumably, in years to come:
How could we identify populations of female workers
who are 100 percent protected against or robust to the
alleged circadian disruption or chronodisruption
[19,21,22] that IARC experts expect to be the critical
link of a causal chain which “probably” leads to cancer?
How should we organise the shift regimens and condi-
tions to become 100 percent innocuous?
Therefore, taken together, the scenario we would want
for sensible calculations and interpretation of AFs and
attributable caseload estimates regarding shift-work and
breast cancer, as dissected by Poole [18] almost a decade
ago, may be impossible to defend with today’s
knowledge.
Regarding (iii): Are the assumptions for calculations of
“attributable fractions and numbers for cancer mortality
and incidence using risk estimates from the literature
and national data sources to estimate proportions
exposed” [10]understood and fulfilled?
With regard to (iii), we - and presumably others -
have concerns related to the very methodology used to
calculate AFs. At least at this stage, they may not be
interpretable. Four possible methodological pitfalls were
raised in public by Morfeld at the 19
th and 20
th Interna-
tional Conferences on Epidemiology in Occupational
Health in Banff, Canada, and San José, Costa Rica,
respectively (see also [23]): (a) The use of Levin’s 1953
[24] formula in case of adjusted relative risks; (b) The
use of broad exposure definitions (e.g., a binary expo-
sure indicator) in calculations of AFs; (c) The non-addi-
tivity of attributable fractions across different exposures
and covariables; (d) The fact that excess mortality fig-
ures are misleading because all human beings die exactly
once - deaths may occur advanced or may be postponed
but no extra deaths or avoided deaths exist.
In the following, we will address methodological pit-
falls (1) through (4). We shall do that by examining sev-
eral theoretical shortcomings. For readers who prefer a
non-theoretical refutation of the assertion that the AFs
used in [9,10] can be interpreted without ambiguity we
shall point to published [(1), (2) and (4)] or provide own
[(3)] examples with data sets where such assertions lead
to open questions.
Methodological pitfall (1)
Levin’s formula applied to adjusted risk estimates
The population attributable fraction AF is defined “as
the proportion of disease cases over a specified time
that would be prevented following elimination of the
exposures, assuming the exposures are causal” [25]; p.
15]. To derive expressions for AF we define RRtrue as
the true relative risk [26]; counterfactual], RRcrude as the
observed relative risk without any adjustments per-
formed and RRadj as the adjusted relative risk after tak-
ing confounders into account. Then, AF = pd(RRtrue-1)/
RRtrue with pd = proportion of cases in the population
exposed to the risk factor. Assuming a successful adjust-
ment of confounders the true relative risk and the
adjusted relative risk are identical: RRtrue =R R adj.T h e n
AF = pd(RRadj-1)/RRadj (cp. Formula 4, Table 1 in [25]).
This formula is often referred to as “Miettinen’sf o r -
mula” [27]. Under the additional assumption of no con-
founding, i.e., RRadj =R R crude,w eo b t a i nA F=p
(RRcrude-1)/[p(RRcrude-1)+1] with p = proportion of
exposed subjects in the population (cp. Formula 2,
Table 1 in Rockhill et al. 1988 [25]). This formula is
often referred to as “Levin’sf o r m u l a ” [24]. Note that
Levin’s formula is guaranteed to be valid only if no con-
founding occurs. Because epidemiological cancer studies
usually adjust relative risk estimates, at least for strong
potential confounders like age or sex, the application of
Levin’s formula in deriving AFs leads to doubtful results
in the standard setting. For further discussions see
Rockhill et al. [25].
A recent systematic exploration illustrates the inherent
problems when applying Levin’s formula in AF compu-
tations. In 2011 Drs. Darrow and Steenland [28] showed
that the use of Levin’s 1953 formula [24] in case of
adjusted relative risks - as applied in [9,10] in a number
of situations - can mislead in significant ways. Darrow
and Steenland [28] performed extensive sensitivity ana-
lyses under realistic conditions and concluded in their
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fraction on the order of 20% might be considered sub-
stantial, given that estimates of AF are bounded by 0
and 1.” Thus, they confirmed the non-negligible poten-
tial degree of bias that had already been demonstrated
by Greenland [29] in the 1980s (downward bias) and
Flegal and co-workers [30] more recently (upward bias).
The reader who prefers to be convinced by example is
invited to have a look at Table 1 and the Example calcu-
lation given by Greenland [29]. He showed that the
downward bias in the AF by applying Levin’sf o r m u l a
was about 15% in that situation. Note that this kind of
bias is expected to occur if any kind of adjustment is
performed (because, in that case, confounding is
assumed to be non-negligible). Thus, an adjustment of
cancer mortality by age suffices - a basic procedure that
should have happened in all situations when Levin’s for-
mula [24] was applied in [9,10].
Methodological pitfall (2)
AF calculation based on a broad definition of exposure
When employing simplified definitions of exposure in
[9,10], this use of broad definitions (e.g. binary exposure
indicator) in calculations of attributable fractions can be
“misleading for projecting the impact of exposure reduc-
tion” [31]. Greenland’s main argument is obvious and he
demonstrated the bias by example. The argument runs
as follows: If the exposure distributions among the tar-
get and the source populations differ the use of broad
definitions of exposure may lead to biased estimates of
the attributable fraction (even if the AF is collapsible
when analysing the source population). This is so
because the result of collapsing data into broad cate-
gories depends on the exposure distribution. If the study
was from Norway (source) but applied to Britain (target)
and exposure distributions differ between the popula-
tions of Norway and Britain the collapsed Norwegian
effect estimate does not necessarily apply to the British
population. Table 1 and Example 2 in [31] gave a
worked example with real data from Sweden (source)
and the US (target): the biased AF using a dichotomiza-
tion of exposure was 25%, whereas it was 15% when
using three exposure categories. Greenland listed meth-
odological papers that showed how to avoid this error.
The author concluded that “it is important to obtain
and use detailed exposure and covariate information for
attributable fraction estimation” [31]. The authors in
[9,10] were probably not able to follow this methodolo-
gical advice given the data available. They almost always
applied broad definitions of exposure: “CAREX was used
for estimating the numbers of the British population
ever exposed to a carcinogen by industry sector....Indus-
try sectors were ... allocated to ‘higher’ or ‘lower’ expo-
sure categories assuming distributions of exposure and
risk that corresponded broadly to those of the studies
from which the risk estimates were selected” [10]; p.
1429). Furthermore, it is unclear why the word “ever
exposed”, should have the same meaning in the epide-
miological studies (source for estimates of relative risk)
and the CAREX exposure system (source for estimates
of number of exposed) [32], both applied in the AF esti-
mation process in [9,10].
Methodological pitfall (3)
Non-additivity of AFs
This concern pertains to the non-additivity of attributa-
ble fractions across different exposures and covariables.
Non-additivity can be observed even if the exposures
are assumed to be mutually exclusive within the popula-
tion. To see why let us suppose that there are two expo-
sures and one endpoint (cancer) of interest: Let p1 be
the prevalence of exposure 1, p2 the prevalence of expo-
sure 2 and p12 the joint prevalence of exposure 1 and
exposure 2. Relative risks associated with these expo-
sures are denoted as RR1,R R 2 and RR12 respectively.
For the sake of simplicity, let us assume that no con-
founding exists so that we may rely on Levin’sf o r m u l a
[24]. We obtain for the single exposure attributable frac-
tions: AF1 =p 1(RR1-1)/(1+p1(RR1-1)), AF2 =p 2(RR2-1)/
(1+p2(RR2-1)). The excess relative risk is ERR = (RR1-1)
(p1-p12)+(RR2-1)(p2-p12)+(RR12-1)p12. Thus the AFoverall
related to both exposures in the population is AFoverall =
ERR/(ERR+1). Example: p1 =0 . 2 ,p 2 =0 . 3 ,R R 1 =2 ,R R 2
=3 ,p 12 = 0 (mutual exclusive exposures): AF1 = 0.167,
AF2 = 0.375, ERR = 0.8 and AFoverall = 0.445. However,
AFsum =A F 1+AF2 = 0.542. Thus, the AFs do not add to
AFoverall even when exposures are mutually exclusive in
the population. Note also that the sum of AFs may
exceed 1 although there is no synergy. If a multiplicative
model is assumed we may try AFmult = 1-(1-AF1)(1-AF2)
as an estimate of AFoverall,s e eE q u a t i o n5i n[ 5 ] .W h e n
applying this formula to our example we get AFmult =
0.479, again a biased estimate in comparison to the true
AFoverall = 0.445. This non-combinability complicates
interpretations of AFs when used for planning interven-
tions. In [10] the use of AFmult is restricted to joint
exposures of the same group (total overlap of exposures)
to avoid some of these complications. However, the sin-
gle AFs depend on the elimination sequence of expo-
sures and confounders in such a population [33].
Therefore, the AFoverall r e l a t e dt oag r o u po fe x p o s u r e s
depends on how and when we intervene on (e.g.,
remove) confounders.
These complications are known. Eide and Gefeller
provided a unique solution by introducing average attri-
butable fractions [33,34]. This concept solves the pro-
blem of dividing the total proportion of excess cases
attributable to the entire set of exposures and
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ponents. The attributable excess cases calculated from
the average attributable fractions are always additive
across all exposures and confounders. Thus, this con-
cept is applicable for solving the problem of shared
responsibilities for the occurrence of excess cases in a
population. The usual attributable fractions as calculated
in [9,10] fail to do so.
Methodological pitfall (4)
Excess deaths vs. premature deaths
Excess mortality figures may be misleading because all
human beings die exactly once. Deaths may be advanced
or may be postponed but, ultimately, there are no extra
deaths or avoided deaths. A definition of advanced and
postponed deaths in terms of “years of life lost” and
“potential years of life lost” is given in [35] applying a
counterfactual framework of causality. “The all-to-easy
interpretation is that deaths attributed to Factor X will
be avoided if exposure to X ceases. Authors may or may
not acknowledge explicitly that these are not “avoidable”
deaths per se, but rather avoidable premature deaths.
Death in the end is not avoidable. Death can merely be
postponed; what can be influenced is not the fact of
death, but its timing” [36], p. 786]. This fact severely
restricts the interpretation of body counts.
Consider an ideal cohort study of N subjects, i.e., all N
subjects die under observation during follow-up and all
causes of death are identified: n0 cancer deaths may
occur without exposure, but n1 given exposure [26]
(counterfactual scenario). Let us assume without loss of
generality n1 >n 0. This means that the number of non-
cancer deaths is N-n0 without exposure and N-n1 under
exposure. Because n1 >n 0 we have N-n1 <N - n 0.T h i s
means that exposure is beneficial in terms of body
counts when studying non-cancer deaths but detrimen-
tal when studying cancer deaths. It follows that the con-
cept of excess deaths calculated from attributable
fractions is confusing as an effect measure of the out-
come of exposures. This becomes in particular clear
when the methodology is applied to all causes of death.
If the all cause Standardised Mortality Ratio (SMR) > 1
we expect more deaths under exposure than without
exposure when applying the excess death methodology
as outlined in [9,10]. However, even without exposure
all subjects will die, thus the calculated excess deaths
are meaningless: we arrive at the contradiction that
more people will die in the exposed cohort than were
ever enumerated for study.
One of the problems related to timing may be demon-
strated by considering the role of life expectancy in an
experimental setting. Consider a medication without
side effects that reduces the incidence of heart diseases
and, in consequence, heart disease mortality. Without
doubt, such an ideal medication is beneficial and pro-
tracts life expectancy. If such a medication is given to a
cohort still all subjects will die but diseases causing
death will potentially change, in particular at higher
ages, from heart diseases to other causes, like cancer.
When discussing this situation of competing causes of
death Lopez wrote [37]; p. 68]: “Given the inevitability
of death, a decline in the proportionate mortality from
one cause must be compensated by a rise in the propor-
tion of deaths ascribed to others. It is, therefore, prob-
able that persons who previously would have
succumbed to one of the cardiovascular diseases (CVDs)
are now dying from cancer.” Thus, we expect to see, in
total, more cancer cases and cancer deaths in a cohort
exposed to the medication than in a control cohort
unexposed [26]; counterfactual comparison]. We arrive
at the paradoxical conclusion that the exposure to this
beneficial medication should be restricted because an
excess of cancers and cancer deaths is calculated under
exposure following the methods used in [9,10]. Thus, an
application of these cancer burden methods in deriving
and discussing limit values for exposures [11] suffers
from potential bias. Lopez identified the reason for this
potential bias: “However, what is important is not
whether these “saved” persons are dying from cancer (or
any other cause) but the age at which they are dying
from competing causes.” [37]; p. 68].
This fundamental problem also affects an informed
interpretation of specific excess fractions, e.g., the excess
deaths from lung cancer. Greenland [38] presented an
example on thyroid cancer in women showing that the
p r o b l e mc a n n o tb eo v e r c o m eb ya s s u m i n gt h er a r ed i s -
ease assumption. These difficulties are not restricted to
risks (cumulative incidence) but also occur when rates
are analysed - even when applying sophisticated proce-
dures like Cox modelling techniques [35].
Conclusions
In their discussion of the example chosen by us to illus-
trate possible problems which arise when calculating
AFs, the authors [10] wrote: “The ramifications of this
decision [Denmark recently became the first country to
designate breast cancer as an occupational disease eligi-
ble for receiving compensation] and of our results could
be significant, given the large numbers of women work-
ing night shifts in Britain and worldwide”.W ec e r t a i n l y
agree here. We tend to disagree, however, insofar that
the aforementioned areas of concern, (i), (ii) and (iii),
could serve as possible warning signals with regard to
analytical results which - at least at the present time -
may be open to several questions.
Overall, that “a significant challenge lying ahead of us
worldwide is circadian or chronodisruption and possible
causal links with diseases, including cancers” is beyond
Erren and Morfeld Epidemiologic Perspectives & Innovations 2011, 8:4
http://www.epi-perspectives.com/content/8/1/4
Page 5 of 7dispute [13,14,39]. To meet this challenge, and to
answer whether shift-work that involves circadian or
chronodisruption is causally linked with internal can-
cers, we need interpretable research. However, at this
stage of uncertainty, how should possibly concerned
female shift-workers interpret - how should they deal
with - statements such as roughly one in two cases of
occupationally related breast cancer in women is attrib-
uted to shift-work? Beyond the outlined methodological
uncertainties, future research may actually show that
shift-work involving circadian or chronodisruption does
not contribute to cancer. In that case not one female
occupationally related breast cancer case would be attri-
butable to shift-work. On the other hand, the BOD attri-
butable to shift-work could be computed to be much
higher than “postulated”, [10] if research were to
demonstrate not only a causal link between shift-work
and breast cancer, but also between shift-work and
prostate cancer [21,22,39].
To reiterate, it is to the credit of Dr. Rushton and her
colleagues for having combined and analysed large data-
bases to attribute incident cancers and cancer deaths to
occupational factors. Nevertheless, that combining such
diverse databases and complex methodologies may lead
to biases should be viewed as the expectation, rather
than the exception. Our commentary was intended to
point to a number of respective questions. The key task
is not to find out whether there may be biases involved
but rather to quantify the extent of those biases now. In
this vein, we are curious to learn from the authors how
much the calculated fractions and case numbers given
in [9,10] may be plausibly biased.
Finally, please note that our comments on specific
analyses in [9,10] on shift-work and breast cancer are
merely intended to exemplify problems which possibly
pertain to BOD studies [1,3,6] more generally. In parti-
cular, the application of the BOD methodology to calcu-
late the cancer burden related to occupational exposures
in Europe, and the extension of these calculations to
socio-economic assessments [12] are likely to be
affected.
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